Table of Contents
ISRN Hematology
Volume 2013, Article ID 232519, 6 pages
http://dx.doi.org/10.1155/2013/232519
Clinical Study

Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan

1Department of Pathology and Microbiology, The Aga Khan University and Hospital, P.O. Box 3500, Stadium Road, Karachi 74800, Pakistan
2Department of Medicine, The Aga Khan University and Hospital, P.O. Box 3500, Stadium Road, Karachi 74800, Pakistan

Received 13 May 2013; Accepted 16 June 2013

Academic Editors: I. Lemasson and P. L. Weiden

Copyright © 2013 Natasha Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. R. Appelbaum, “Haematopoietic cell transplantation as immunotherapy,” Nature, vol. 411, no. 6835, pp. 385–389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Urbano-Ispizua, “Risk assessment in haematopoietic stem cell transplantation: stem cell source,” Best Practice and Research Clinical Haematology, vol. 20, no. 2, pp. 265–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Aschan, “Risk assessment in haematopoietic stem cell transplantation: conditioning,” Best Practice and Research Clinical Haematology, vol. 20, no. 2, pp. 295–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. M. Ferrara and P. Reddy, “Pathophysiology of graft-versus-host disease,” Seminars in Hematology, vol. 43, no. 1, pp. 3–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Couriel, H. Caldera, R. Champlin, and K. Komanduri, “Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management,” Cancer, vol. 101, no. 9, pp. 1936–1946, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. M. Ball and R. M. Egeler, “Acute GvHD: pathogenesis and classification,” Bone Marrow Transplantation, vol. 41, supplement 2, pp. S58–S64, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. M. Shulman, K. M. Sullivan, and P. L. Weiden, “Chronic Graft-Versus-Host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients,” The American Journal of Medicine, vol. 69, no. 2, pp. 204–217, 1980. View at Google Scholar · View at Scopus
  8. A. C. Vigorito, P. V. Campregher, B. E. Storer et al., “Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD,” Blood, vol. 114, no. 3, pp. 702–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Flomenberg, L. A. Baxter-Lowe, D. Confer et al., “Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome,” Blood, vol. 104, no. 7, pp. 1923–1930, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. J. Martin, G. Schoch, L. Fisher et al., “A retrospective analysis of therapy for acute graft-verus-host disease: initial treatment,” Blood, vol. 76, no. 8, pp. 1464–1472, 1990. View at Google Scholar · View at Scopus
  11. J.-Y. Cahn, J. P. Klein, S. J. Lee et al., “Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thërapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study,” Blood, vol. 106, no. 4, pp. 1495–1500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Teshima, T. A. Wynn, R. J. Soiffer, K.-I. Matsuoka, and P. J. Martin, “Chronic Graft-versus-Host Disease: how Can We Release Prometheus?” Biology of Blood and Marrow Transplantation, vol. 14, no. 1, pp. 142–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Sullivan, H. M. Shulman, and R. Storb, “Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression,” Blood, vol. 57, no. 2, pp. 267–276, 1981. View at Google Scholar · View at Scopus
  14. A. H. Filipovich, D. Weisdorf, S. Pavletic et al., “National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report,” Biology of Blood and Marrow Transplantation, vol. 11, no. 12, pp. 945–956, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Rowe, N. Ciobanu, J. Ascensao et al., “Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation: a report from the Eastern Cooperative Oncology Group (ECOG),” Annals of Internal Medicine, vol. 120, no. 2, pp. 143–158, 1994. View at Google Scholar · View at Scopus
  16. P. Sodani, D. Gaziev, P. Polchi et al., “New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years,” Blood, vol. 104, no. 4, pp. 1201–1203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Przepiorka, D. Weisdorf, P. Martin et al., “Consensus conference on acute GVHD grading,” Bone Marrow Transplantation, vol. 15, no. 6, pp. 825–828, 1995. View at Google Scholar · View at Scopus
  18. U. Platzbecker, G. Ehninger, and M. Bornhäuser, “Allogeneic transplantation of CD34+ selected hematopoietic cells —clinical problems and current challenges,” Leukemia and Lymphoma, vol. 45, no. 3, pp. 447–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Marmont, M. M. Horowitz, R. P. Gale et al., “T-cell depletion of HLA-identical transplants in leukemia,” Blood, vol. 78, no. 8, pp. 2120–2130, 1991. View at Google Scholar · View at Scopus
  20. S. S. B. Randolph, T. A. Gooley, E. H. Warren, F. R. Appelbaum, and S. R. Riddell, “Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants,” Blood, vol. 103, no. 1, pp. 347–352, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. D. Flowers, Y. Inamoto, P. A. Carpenter et al., “Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria,” Blood, vol. 117, no. 11, pp. 3214–3219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kondo, S. Kojima, K. Horibe, K. Kato, and T. Matsuyama, “Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children,” Bone Marrow Transplantation, vol. 27, no. 7, pp. 727–730, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. E. W. Petersdorf, G. M. Longton, C. Anasetti et al., “The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation,” Blood, vol. 86, no. 4, pp. 1606–1613, 1995. View at Google Scholar · View at Scopus
  24. P. Loiseau, M. Busson, M.-L. Balere et al., “HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival,” Biology of Blood and Marrow Transplantation, vol. 13, no. 8, pp. 965–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Hashmi, B. Khan, P. Ahmed et al., “Graft versus host disease in allogeneic stem cell transplantation —3 1/2 Years experience,” Journal of the Pakistan Medical Association, vol. 55, no. 10, pp. 423–427, 2005. View at Google Scholar · View at Scopus
  26. A. Ghavamzadeh, K. Alimogaddam, M. Jahani et al., “Stem cell transplantation; Iranian experience,” Archives of Iranian Medicine, vol. 12, no. 1, pp. 69–72, 2009. View at Google Scholar · View at Scopus
  27. D.-H. Liu, X.-S. Zhao, Y.-J. Chang et al., “The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation,” Pediatric Blood and Cancer, vol. 57, no. 1, pp. 135–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. J. Shaw, F. Kan, K. W. Ahn et al., “Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors,” Blood, vol. 116, no. 19, pp. 4007–4015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Sorror, B. M. Sandmaier, B. E. Storer et al., “Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies,” Journal of the American Medical Association, vol. 306, no. 17, pp. 1874–1883, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. O. G. Cantu-Rodriguez, C. H. Gutierrez-Aguirre, J. C. Jaime-Perez, O. R. Trevino-Montemayor, S. A. Martinez-Cabriales, A. Gomez-Pena et al., “Low incidence and severity of graft-versus-host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced-intensity conditioning,” European Journal of Haematology, vol. 87, no. 6, pp. 521–530, 2011. View at Google Scholar
  31. Y.-J. Chang, C.-L. Weng, L.-X. Sun, and Y.-T. Zhao, “Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials,” Annals of Hematology, vol. 91, no. 3, pp. 427–437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Auberger, J. Clausen, B. Kircher, G. Kropshofer, B. Lindner, and D. Nachbaur, “Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients,” The European Journal of Haematology, vol. 87, no. 6, pp. 531–538, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Gratwohl, R. Brand, F. Frassoni et al., “Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time,” Bone Marrow Transplantation, vol. 36, no. 9, pp. 757–769, 2005. View at Publisher · View at Google Scholar · View at Scopus